Keywords: fda, requests, data, schering, yasmin, ag, subsidiary

FDA requests more data for Schering's Yasmin

Article | 20 July 2000

Print This

Schering AG's US subsidiary, Berlex Laboratories, has received anapprovable letter from the US Food and Drug Administration for the oral ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in